Healthcare

GlucoTrack (NASDAQ: GCTK) has outlined plans to pursue U.S. regulatory clearance for its glucose monitoring device, a development that quickly

iTonic Holdings (NASDAQ: ITOC) announced a $20 million private placement deal on Monday, sparking a sharp rally in after-hours trading—even

Scienture Holdings (NASDAQ: SCNX) has secured several group purchasing organization (GPO) agreements that significantly expand institutional access to its overdose

ImmunityBio (NASDAQ: IBRX) unveiled a new international partnership designed to expand global access to its cancer therapy, Anktiva. Specifically, the

Shares of Hims & Hers Health (NYSE: HIMS) plunged nearly 10% in regular trading on Tuesday as investors digested a

Novo Nordisk (NYSE: NVO) said it plans to pursue legal and regulatory action against telehealth provider Hims & Hers Health

UnitedHealth Group shares (NYSE: UNH) plunged after U.S. regulators signaled minimal growth in future Medicare Advantage payments, overshadowing the company’s

Shares of 60 Degrees Pharmaceuticals (NASDAQ: SXTP) jumped 152% Thursday to an intraday 52-week high after the company announced a

RAPT Therapeutics stock (NASDAQ: RAPT) surged 63.86% to $57.52 in morning trading after GSK announced plans to acquire the biotech

Novo Nordisk shares (NYSE: NVO) surged on Friday after UK regulators approved a higher maximum dose of its blockbuster obesity

Did you know that the worldwide biotechnology industry is expected to increase at a CAGR of 13.96% from 2024 to